AMZN
Amazon.com, Inc.
AMZN has the edge over MYE overall, supported by stronger valuation and stronger modeled upside.
MYE
Myers Industries, Inc.
MYE's outlook is improving despite an expensive valuation.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MYE Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Healthy | |
| Stable |
MYE's profitability and cash flow are currently healthy, and its balance sheet is stable, but its revenue is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over MYE in the historical PE scenario, which offers more potential upside but is not a forecast.
MYE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $10.18 | -64% |
| Forward | 14x | $28.32 | — |
| Fair | 20x | $15.32 | -46% |
| Expensive | 31x | $23.28 | -18% |
| Current | 37x | $28.32 | — |
Historical ranges are pointers, not guarantees.
MYE's PE is in its expensive range at 37x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
MYE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect MYE's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over MYE on earnings, with more consistent year-over-year improvement.
MYE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.00 | +163% |
| Q3 2026 | $0.76 | +2.7% |
| Q2 2026 | $0.97 | +273% |
| Q1 2026 | $0.70 | +150% |
| Q4 2025 | $0.93 | +389% |
| Q3 2025 | $0.74 | +76% |
| Q2 2025 | $0.26 | -75% |
| Q1 2025 | $0.28 | -74% |
| Q4 2024 | $0.19 | -86% |
MYE's earnings per share have fallen from their peak: $0.76 over the past year, against $1.64 in late 2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over MYE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over MYE on profitability, with a higher operating margin.
MYE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $171.3M | -17% |
| Q2 2026 | $179.2M | -14% |
| Q1 2026 | $164.6M | -20% |
| Q4 2025 | $204M | 0% |
| Q3 2025 | $205.4M | +0.2% |
| Q2 2025 | $209.6M | -4.8% |
| Q1 2025 | $206.8M | -0.2% |
| Q4 2024 | $203.9M | +6.7% |
MYE's revenue has slid since its 2022 peak: $171M last quarter, down 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.7% | +0.1 points |
| Q2 2026 | 17% | +7.9 points |
| Q1 2026 | 15% | +7 points |
| Q4 2025 | 9.9% | +2.7 points |
| Q3 2025 | 8.6% | +11 points |
| Q2 2025 | 9.5% | -1.2 points |
| Q1 2025 | 8.1% | +2.8 points |
| Q4 2024 | 7.2% | -2.6 points |
MYE's operating margin was 8.7% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
MYE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.1M | -48% |
| Q2 2026 | $27.9M | +13% |
| Q1 2026 | $23.4M | +1044% |
| Q4 2025 | $18.9M | -6.3% |
| Q3 2025 | $21.5M | +112% |
| Q2 2025 | $24.7M | +149% |
| Q1 2025 | $2M | -86% |
| Q4 2024 | $20.2M | +71% |
MYE has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over MYE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MYE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +136K shares |
| 1 year | +0.9% | +345K shares |
| 3 years | +2.6% | +947K shares |
| 5 years | +4.2% | +1.5M shares |
| Available history | +6.4% | +2.3M shares |
MYE has 38M diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $504,000 |
| Q3 2025 | $506,000 |
| Q2 2025 | $507,000 |
| Q1 2025 | $1M |
MYE has spent almost nothing on buybacks in the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over MYE on leverage, with a lower net debt burden relative to earnings.
MYE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 3.3x | Elevated |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 4.4x | High |
| Q1 2025 | 4.1x | High |
| Q4 2024 | 4.1x | High |
MYE's net debt is about 2.3 years of its operating earnings (EBITDA), down from 3.4 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MYE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.8 | Neutral |
| Stochastic | 14.9 | Oversold |
MYE's weekly RSI is 48 (neutral) and its Stochastic is 15 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over MYE on valuation relative to its sector.
MYE PE vs Consumer Cyclical Sector
| Metric | MYE | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 18x | 107% above |
| PE % | 88 | 47 | 41 pts above |
MYE is trading at 37x earnings, a 107% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over MYE on trend strength, trading above more of its moving averages.
MYE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.2 | 6.3% below |
| 20 week MA | $31.4 | 9.7% below |
| 50 week MA | $25.7 | 10% above |
| 100 week MA | $19.8 | 43% above |
| 200 week MA | $18.9 | 50% above |
MYE has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 50% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
MYE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.5 | $20.3 | +23% |
| 2021 | $20.3 | $19.7 | -2.8% |
| 2022 | $19.7 | $23.1 | +17% |
| 2023 | $23.1 | $19.6 | -15% |
| 2024 | $19.6 | $11.1 | -43% |
| 2025 | $11.1 | $19.3 | +74% |
| 2026 YTD | $19.3 | $28.3 | +47% |
MYE has the edge over AMZN on returns for 2026, with the stronger performance.